Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Journal of Allergy and Clinical Immunology Année : 2018

Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma

Fichier principal
Vignette du fichier
2019 Khatri et al., Assessement of the.pdf (47.8 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-01906456 , version 1 (07-06-2020)

Identifiants

Citer

Sumita Khatri, Wendy Moore, Peter Gibson, Richard Leigh, Arnaud Bourdin, et al.. Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma. Journal of Allergy and Clinical Immunology, 2018, ⟨10.1016/j.jaci.2018.09.033⟩. ⟨hal-01906456⟩
37 Consultations
5 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More